Literature DB >> 11173042

Introduction. The role of COX-2-specific inhibitors in clinical practice.

P E Lipsky1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11173042     DOI: 10.1016/s0002-9343(00)00676-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  4 in total

1.  Factors that influence prescribers in their selection and use of COX-2 selective inhibitors as opposed to non-selective NSAIDs.

Authors:  Anna I Gunnarsdóttir; Moira Kinnear
Journal:  Pharm World Sci       Date:  2005-08

Review 2.  NSAID-related psychiatric adverse events: who is at risk?

Authors:  Graziano Onder; Francesca Pellicciotti; Giovanni Gambassi; Roberto Bernabei
Journal:  Drugs       Date:  2004       Impact factor: 9.546

3.  The COX-2 inhibitors, meloxicam and nimesulide, suppress neurogenesis in the adult mouse brain.

Authors:  Maria Beatriz Goncalves; Emma-Jane Williams; Ping Yip; Rafael J Yáñez-Muñoz; Gareth Williams; Patrick Doherty
Journal:  Br J Pharmacol       Date:  2010-02-05       Impact factor: 8.739

4.  Parecoxib has non-significant long-term effects on bone healing in rats when administered for a short period after fracture.

Authors:  Panagiotis Akritopoulos; Paraskevi Papaioannidou; Ippokratis Hatzokos; Afroditi Haritanti; Eirini Iosifidou; Maria Kotoula; Vassiliki Mirtsou-Fidani
Journal:  Arch Orthop Trauma Surg       Date:  2008-08-02       Impact factor: 3.067

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.